CTT Pharmaceutical Holdings, Inc. Share Price
Equities
CTTH
US12651E1064
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0322 USD | -19.38% | +18.32% | +15.36% |
2020 | CTT Pharmaceutical Holdings, Inc Enters into Business Development Partnership with 3 Rivers Biotech | CI |
2020 | CTT Pharmaceutical Holdings, Inc. Announces Management Appointments | CI |
Sales 2013 | - | Sales 2014 | - | Capitalization | 9.13M 730M |
---|---|---|---|---|---|
Net income 2013 | - 0 | Net income 2014 | - 0 | EV / Sales 2013 * | - |
Net Debt 2013 | 0.02 1.5 | Net Debt 2014 | 0.01 0.49 | EV / Sales 2014 | - |
P/E ratio 2013 * |
-
| P/E ratio 2014 |
35.5
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 14.68% |
1 day | -19.38% | ||
1 week | +18.32% | ||
Current month | -35.40% | ||
1 month | -35.40% | ||
3 months | +29.20% | ||
6 months | -59.68% | ||
Current year | +15.36% |
Managers | Title | Age | Since |
---|---|---|---|
Ryan Khouri
CEO | Chief Executive Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Allen Greenspoon
BRD | Director/Board Member | 69 | 08/09/14 |
Ryan Khouri
CEO | Chief Executive Officer | - | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.0322 | -19.38% | 8,144 |
25/04/24 | 0.04 | +33.78% | 3,500 |
23/04/24 | 0.0299 | +9.72% | 1,000 |
Delayed Quote OTC Markets, April 29, 2024 at 05:11 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+15.36% | 1.62M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- CTTH Stock